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The replication or maintenance of human genomes through cell lineages or across generations is not always completely faithful. Rare mutations accumulate whose eventual fate is to be lost through drift or negative selection or to be fixed in our future population. Although these mutations are random, in the sense that when or where they occur is highly unpredictable, not all base pairs stand an even chance of being mutated, and consequently, there are regions of the human genome that are hotspots, or coldspots, of change. Pinpointing these hotspots might lead to a better understanding of both mutational mechanisms and the frequency by which spontaneous sequence change causes noninherited genetic disease. In this issue of Cell, Michaelson et al. (2012) identify de novo germline mutations in monozygotic twins who are concordant for autism and propose that mutational variation is largely explained by intrinsic characteristics of DNA sequence and chromatin structure.
The authors deep-sequenced immortalized lymphoblastoid cell line genomes from ten pairs of monozygotic twins with autism and from their parents. On average, 58 DNA changes were present in both twins, yet were absent from their parents, and thus were likely to have arisen de novo in their common germline genome, rather than being somatic or cell line mutations. This number translates to an average human genome-wide mutation rate of 1 3 10 À8 per base pair per generation, similar to previous estimates (Conrad et al., 2011; Campbell et al., 2012; Kong et al., 2012; Sun et al., 2012) . Michaelson et al. (2012) then show that the majority of these DNA changes were of paternal origin. This is consistent with mutations being predominantly replication-dependent, having been introduced during the greater number of germline cell divisions in the life history of a sperm relative to that of an egg (Crow, 2000; Veltman and Brunner, 2012 ; see also Kong et al., 2012) . They show that each additional year for fathers between the ages of about 28 and 40 introduces, on average, one de novo mutation to his off-spring's genome. These de novo mutations failed to fall evenly across the genome and some lay within even very short chromosomal regions. Six <100 bp regions contained two or three such mutations linked to the same individual, indicating that these were introduced either as compound heterozygous mutations, in cis simultaneously, or through successive events of gene conversion (see also Campbell et al., 2012) . Michaelson et al. (2012) then use logistic regression to show that de novo mutations were unexpectedly frequent at the small scale (<100 bp) in three sequence classes: simple repeats, DNase 1 hypersensitivity sites from embryonic stem cells, and various trinucleotide sequences. The known high rate of replication slippage in simple repeats likely accounts for the first enrichment. The high mutation rate in DNase 1 hypersensitivity sites is, however, unexpected (Prendergast et al., 2007) but could reflect substantial differences in open chromatin regions between embryonic stem cells and male germ cells. By far the greatest enrichment is that for trinucleotide sequences. In great part, this is explained by the high mutability of the CpG dinucleotide and, to a lesser extent, of the CpNpG trinucleotide arising mostly from the spontaneous deamination of 5mC (Cooper et al., 2011) . Michaelson et al. (2012) found that 15% of their de novo mutations were of the CpG type, a similar proportion to that observed by others (Conrad et al., 2011 [13%] ; Campbell et al., 2012 [17%] ; Kong et al., 2012 [19%] ).
By constructing principal components from a set of 78 quantitative and sequence features of the genome at different linear scales, the authors then define a mutability index (MI) for all sites across the human genome. This index is the log 10 value of the fold-excess of de novo mutations expected from these features; hence, if all sites were equally mutable then they would be associated with MI values of zero. As expected, the majority of CpG sites have high MI values, exceeding 0.5, which is about a 3-fold enrichment of mutations (Figure 1) . Interestingly, the authors predict exonic sequence to be on average 30% more prone to mutation than the genome as a whole, in part perhaps because coding sequence is G+C and CpG-rich. Genes associated with recessive or dominant disease were predicted to show even greater tendencies for being mutated, at approximately 35% and 40% average increases, respectively, results that are in agreement with a previous crossspecies comparison (Huang et al., 2004) . These findings imply that features of such disease genes make them slightly more susceptible to being mutated or to their mutations being repaired less efficiently in germline cells.
Somewhat counterintuitively, proteincoding sequence that has been better conserved, either within or between species, was predicted to be modestly (up to 70%) more prone to mutation. This implies that deleterious variants are more frequently purged from particular classes of protein-coding sequence not just because of their greater effects on fitness but also because they arise, through mutation, more frequently. Overall, these results imply that sequence within genes that contributes to fundamental biological processes is particularly prone to being mutated and through these mutations to contribute to disease.
The Michaelson et al. (2012) study reveals how the mutation rate can vary over three orders of magnitude across the human genome and how CpG-rich or exonic sequence is mutated more frequently. Nevertheless, predicted MI values are not sufficiently accurate to reliably estimate mutation rates at single sites, and MI values could not be used to distinguish a cohort of individuals with autism spectrum disorders (ASD) from healthy individuals. The study's identification of 29 protein-coding genes that contained de novo mutations (of which only ten were exonic) did, however, shed some light on these disorders. For example, two genes, KIRREL2 and GPR98, mutated in an ASD cohort were also mutated in individuals in a replication cohort, thereby elevating their status as excellent ASD candidate genes.
Michaelson et al.'s observations of paternal bias and mutational hotspots in the human genome extend and confirm results from other recent studies (Conrad et al., 2011; Campbell et al., 2012; Kong et al., 2012; Sun et al., 2012) . Together these publications demonstrate how whole-genome sequencing within families has now become sufficiently accurate to catalog an individual's unique set of mutations. Nevertheless, given the extent and variety of mutations they uncovered, these studies highlight the substantial challenges ahead in accurately explaining traits or disorders in terms of de novo variants.
Figure 1. Genomic Features and Mutability
Schematic representation of the range of estimated mutability index (MI) values (x axis) for exon (green), non-CpG (red) and CpG (blue) sequences. The null expectation-that assumes all sequence to be equally mutable-would yield MI = 0 values (black line). Exonic sequence tends to have slightly higher MI values than this expectation, and exons from a set of 93 genes that have been implicated in ASD (''ASD Exons'') tend to have a further modest increase in mutability. Median MI values for exon and ASD gene exon sequences are indicated by green and purple arrows, respectively.
